Streptococcus Pneumoniae antibody

Catalog No. ABIN110942

The Mouse Monoclonal anti-Streptococcus Pneumoniae antibody is suitable to detect Streptococcus Pneumoniae in samples from Streptococcus pneumoniae. It has been validated for IF and EIA.

Quick Overview for Streptococcus Pneumoniae antibody (ABIN110942)

Target: Streptococcus Pneumoniae

Reactivity: Streptococcus pneumoniae

Host: Mouse

Clonality: Monoclonal

Conjugate: This Streptococcus Pneumoniae antibody is un-conjugated

Application: Immunofluorescence (IF), Enzyme Immunoassay (EIA)

Clone: 128-390

Product Details anti-Streptococcus Pneumoniae Antibody

Purification: Affinity Chromatography on Protein A.

Immunogen: Native S. pneumoniae (NCTC 10319).

Isotype: IgG1

Application Details

Application Notes: ELISA. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Streptococcus Pneumoniae

Target: Streptococcus Pneumoniae

Target Type: Bacteria

Background: Bronchial pneumonia is most prevalant in infants, young children and aged adults. It is caused by various bacteria, including Streptococcus pneumoniae. Streptococcus pneumoniae are Gram positive, lancet shaped cocci (elongated cocci with a slightly pointed outer curvature). Usually they are seen as pairs of cocci (diplococci), but they may also occur singly and in short chains. S. pneumoniae is a transient member of the normal flora, colonizing the nasopharynx of 40 % of healthy adults and children with no adverse effects. There are more than 90 serotypes: serotypes 6, 14, 18, 19, and 23 are the most prevalent accounting for 60-80 % of infections depending on the area of the world. Pneumococcal infection accounts for more deaths than any other vaccine preventable bacterial disease.